P08.32 TG02, an oral CDK inhibitor, demonstrates activity in glioma models: EORTC Brain Tumor Group Conducts Phase 1b study (STEAM / EORTC 1608)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.